Investment Rating - The investment rating for the company is "Buy" [3] Core Views - The pre-mixed cocktail segment is under short-term pressure, while the whiskey product line is expected to contribute positively to revenue growth [2][7] - The company launched new whiskey products, including "Bailide" blended whiskey and the "Laizhou" single malt whiskey series, which are anticipated to drive sales [2][7] - The company is focusing on seasonal new product launches to rejuvenate its brand positioning in the pre-mixed cocktail market [7] Revenue and Profitability - For 2024, the company expects revenue of 30.48 billion yuan, a decrease of 6.61% year-on-year, with a net profit of 7.19 billion yuan, down 11.15% [3][7] - The gross margin for 2024 is projected to be 69.67%, with a net margin of 23.50% [2][3] - The company anticipates revenue growth of 9% and 11% for 2025 and 2026, respectively, with net profit growth of 11% and 15% [2][3] Regional Performance - Revenue from different regions for 2024 is as follows: North China 5.56 billion yuan, East China 10.15 billion yuan, South China 9.30 billion yuan, and West China 5.13 billion yuan, with varying year-on-year changes [1][2] Channel Performance - Revenue from distribution and direct sales for 2024 is projected at 21.52 billion yuan and 8.62 billion yuan, respectively, with a year-on-year decrease of 13.30% for distribution and an increase of 19.92% for direct sales [2]

证券研究报告 | 公司点评 | 白酒Ⅱ 老白干酒(600559) 报告日期：2025 年 05 月 13 日 盈利能力持续提升，产品结构逐步升级 ——老白干酒更新报告 投资要点 ❑2024 年营业收入 53.58 亿元（同比+2%）； 归母净利润 7.87 亿元（+18% ）。 25Q1 营业收入 11.68 亿元 （+3%）； 归母净利润 1.52 亿元（+12% ）。 ❑我们认为，公司管理不断提升，五个品牌分区域运作，费用改革成果不断兑 现，盈利能力显著提升。我们看好结构升级+费用管控下的利润弹性释放。 ❑产品结构持续提升，孔府家/武陵酒表现亮眼 1）24 年老白干/板城烧锅/文王贡/孔府家/武陵酒收入 25.90/8.58/5.50/2.30/10.99 亿元，同比+9.96% /-10.33% /+0.53% /+28.12%/+12.30%，吨价+5.35%/+1.84% /+2.52% /+8.83% /+30.34% 。2）25Q1 百元以上酒（出厂价）收入 6.61 亿，同比 +25.50%,占比提升 10pct 至 56.85%。百元以下酒收入 5.02 亿,同比-15.65%。 ❑大本营市 ...

Investment Rating - The investment rating for the company is "Accumulate" [6] Core Views - The company is expected to see a recovery in demand and significant profit growth in 2025, driven by the resumption of hospital bidding and the introduction of high-end products [1][2] - The company's revenue for 2024 is projected to be 10.3 billion yuan, a decrease of 9.7% year-on-year, while the net profit attributable to the parent company is expected to be 1.262 billion yuan, down 36.1% year-on-year [1] - The first quarter of 2025 shows positive revenue growth of 5.4% year-on-year, with net profit attributable to the parent company increasing by 1.9% [1][2] Summary by Sections Revenue and Profitability - In Q4 2024, the company reported revenue of 3.346 billion yuan, a decline of 15.9% year-on-year but a 106% increase quarter-on-quarter [1] - The company’s revenue for Q1 2025 is 2.478 billion yuan, reflecting a year-on-year growth of 5.4% [1] - The net profit for Q1 2025 is 370 million yuan, up 1.9% year-on-year, while the non-recurring net profit is 379 million yuan, showing a significant increase of 26.1% [1] Market Position and Product Development - The company’s market share increased by over 3 percentage points in 2024, particularly in high-end products, which saw a nearly 5 percentage point increase in market share [2] - New product launches in 2024 include the uLinacHalosTx precision radiotherapy system and the uMRMax next-generation 3.0T MRI, which are expected to enhance the company's competitive position [2] International Expansion - The company achieved overseas revenue of 2.22 billion yuan in 2024, a year-on-year increase of 33.81%, with overseas revenue accounting for 21.55% of total revenue [3] - The company has received CE certification for 46 products and FDA approval for 49 products, enhancing its international market presence [3] Profitability Forecast - The gross profit margin for 2024 is expected to be 48.54%, with a slight increase anticipated in 2025 [4] - The net profit margin for 2024 is projected at 12.06%, with expectations for improvement in 2025 as the company benefits from economies of scale [4] Financial Projections - Revenue projections for 2025, 2026, and 2027 are 12.251 billion yuan, 14.478 billion yuan, and 17.325 billion yuan, respectively, with year-on-year growth rates of 18.94%, 18.18%, and 19.67% [5] - The net profit attributable to the parent company is expected to reach 1.799 billion yuan in 2025, reflecting a year-on-year growth of 42.59% [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [4] Core Views - The company is expected to achieve a revenue of 6.015 billion yuan in 2024, representing a year-on-year growth of 0.89%, while the net profit attributable to the parent company is projected to be 1.655 billion yuan, down 3.83% year-on-year. In Q4 2024, revenue reached 1.653 billion yuan, up 9.02%, and net profit was 345 million yuan, down 7.55%. For Q1 2025, revenue is expected to be 1.810 billion yuan, up 2.42%, with a net profit of 610 million yuan, up 3.59% [1][3] - The company is focusing on enhancing its brand and product offerings, particularly in the mid-to-high-end market segments, with the aim of establishing its "Jian Series" as a strategic flagship product [1] - The company has increased its marketing expenditures to support distributors and leverage its brand advantages, which is anticipated to yield positive results over time [1] Financial Summary - In 2024, the revenue breakdown by product category shows high-end liquor generating 5.681 billion yuan (up 0.06%), mid-range liquor at 6.8 million yuan (down 10.35%), and low-end liquor at 12.6 million yuan (up 33.01%). For Q1 2025, high-end liquor revenue is 1.728 billion yuan (up 3.53%), mid-range liquor at 2.1 million yuan (down 12.50%), and low-end liquor at 3.9 million yuan (down 9.00%) [1] - The company has seen an increase in the number of distributors, with 502 in the province and 517 outside the province as of 2024, reflecting a strategic focus on both local and regional markets [1] - The gross margin for 2024 is projected to be 74.59%, with a slight decrease in net profit margin to 27.52% [8] Earnings Forecast and Valuation - The revenue growth forecast for 2025 and 2026 has been slightly adjusted to 1% and 4%, respectively, with net profit growth estimates revised to 2% and 6%. The forecast for 2027 anticipates revenue and net profit growth of 5% and 7%, respectively [3] - The price-to-earnings (P/E) ratio is projected to decrease from 13.27 in 2024 to 11.45 by 2027, indicating a potential increase in valuation attractiveness over time [9]

证券研究报告 | 行业深度 | 家用电器 如何看待小米大家电 2025 年的增长持续性？ ——家用电器行业深度报告 投资要点 2024 年小米白电规模大幅增长，黑电经营质量提升 2024 年小米智能大家电收入同比增长 56.4%；其中空调出货量 680 万台，同比增长超 50%。2024 年小米品牌电视线上零售均价同比增长 57%（奥维云网），价格指数大幅提 升，并且红米电视线上零售市场份额提升显著。我们认为小米 2024 年在家电领域的成 功来自于：1）天时：顺应消费降级趋势；2）地利：薄利多销的打法、持续差异化产品 创新的能力、造车及企业家 IP 引流的营销方式；3）人和：改造大家电事业部，家电 在人车家全生态战略地位提升。 2025 年空调：中低端市场竞争加剧，小米向更高价格带寻求突破。 1）2025 年国补政策有所调整，空调释放销量弹性，但预计价格弹性不大。线上 2100~2700 元核心价格带竞争加剧。本轮国补一个消费者至多可以补贴三台空调，因 此空调量增明显，25 年国补以来，冰箱、洗衣机、空调线上销量同比-7%、+1%、+6%， 空调跑赢其他白电；但 25Q1 空调线上零售均价同比-3%，反映当 ...

Investment Rating - The investment rating for the company is "Accumulate" [6] Core Views - The company is expected to see a recovery in demand and significant profit growth in 2025 due to the resumption of hospital bidding and the introduction of high-end products [2][4] - The company's revenue for 2024 is projected to be 10.3 billion yuan, a decrease of 9.7% year-on-year, while the net profit attributable to the parent company is expected to be 1.262 billion yuan, down 36.1% year-on-year [1][5] - The company is expanding its overseas market presence, with overseas revenue reaching 2.22 billion yuan in 2024, a year-on-year increase of 33.81% [3] Summary by Sections Financial Performance - In Q4 2024, the company reported revenue of 3.346 billion yuan, a year-on-year decrease of 15.9%, but a quarter-on-quarter increase of 106% [1] - For Q1 2025, revenue is expected to be 2.478 billion yuan, a year-on-year increase of 5.4%, with net profit attributable to the parent company at 370 million yuan, up 1.9% year-on-year [1][5] Growth Potential - The company’s market share in high-end products is expected to continue to rise, with a nearly 5 percentage point increase in 2024 [2] - The introduction of innovative products such as the uLinacHalosTx precision radiotherapy system and the uMRMax next-generation 3.0T MRI is anticipated to drive growth [2] Profitability Outlook - The gross profit margin for 2024 is projected to be 48.54%, with an expected increase to 49.94% in Q1 2025 [4] - The net profit margin for 2024 is expected to be 12.06%, with an anticipated increase in 2025 due to the recovery of hospital bidding and improved operational efficiency [4] Revenue Forecast - The company’s total revenue is forecasted to be 12.251 billion yuan in 2025, representing a year-on-year growth of 18.94% [5] - The net profit attributable to the parent company is expected to reach 1.799 billion yuan in 2025, a year-on-year increase of 42.59% [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Views - The company is a leading player in the high-pressure cleaning machine sector, experiencing accelerated growth, while its general machinery business shows steady growth [2] - The company's revenue and profit for 2024 and Q1 2025 exceeded expectations, driven by increased orders in general power machinery and high-pressure cleaning machines [5][6] - The company is expanding its production capacity and entering the energy storage sector, which is expected to become a new growth point [5][6] Financial Performance Summary 1) Revenue & Profit: - 2024 full year revenue reached 2.25 billion, a year-on-year increase of 38.3%, with net profit attributable to shareholders at 190 million, a year-on-year increase of 3.4% [5] - Q4 2024 revenue was 680 million, a year-on-year increase of 72.5%, with net profit of 50 million, a year-on-year increase of 55.9% [5] - Q1 2025 revenue was 640 million, a year-on-year increase of 50.1%, with net profit of 60 million, a year-on-year increase of 56.3% [5] 2) Profitability: - The gross margin for 2024 was 18.1%, down 4.0 percentage points year-on-year, while the net profit margin was 8.3%, down 2.8 percentage points [5] - In Q1 2025, the gross margin improved to 20.0%, up 0.9 percentage points year-on-year, with a net profit margin of 9.0%, up 0.4 percentage points [5] 3) Expense Structure: - The total expense ratio for 2024 was 7.4%, down 0.2 percentage points year-on-year, with R&D expenses increasing due to investments in energy storage product development [5] - In Q1 2025, the total expense ratio was 7.7%, up 0.9 percentage points, primarily due to an increase in financial expenses [5] Business Segmentation - High-pressure cleaning machine business generated 1.09 billion in revenue in 2024, a year-on-year increase of 70.1%, with a gross margin of 20.6% [5] - General machinery revenue was 1 billion in 2024, a year-on-year increase of 14.2%, with a gross margin of 13% [5] - The energy storage segment generated 10 million in revenue in 2024, with a gross margin of 19.2% [5] Earnings Forecast and Valuation - The company is expected to achieve revenues of 2.87 billion, 3.76 billion, and 4.96 billion in 2025, 2026, and 2027, respectively, with corresponding net profits of 247 million, 331 million, and 455 million [6] - The current market valuation corresponds to a PE ratio of 12.4 for 2025, indicating that the company is undervalued compared to industry averages [6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company's performance in 2024 was under pressure due to declining profitability in the organic solvent segment, but there is optimism for future growth in the fragrance and lithium resource businesses [3][4] - The company achieved a revenue of 2.966 billion yuan in 2024, a year-on-year increase of 14.22%, while the net profit attributable to shareholders was 227 million yuan, a decrease of 10.18% [2][3] - The company has established a strong position in the synthetic fragrance market and is expanding its production capacity in both Ningxia and Jiangsu, which is expected to enhance its competitive edge [4][5] Financial Summary - In 2024, the company reported a revenue of 29.66 billion yuan, with a net profit of 2.27 billion yuan, and a return on equity of 10.19% [2][3] - For Q1 2025, the company achieved a revenue of 7.65 billion yuan, a year-on-year increase of 2.81%, and a net profit of 0.72 billion yuan, a decrease of 5.98% [2][3] - The projected net profits for 2025, 2026, and 2027 are 3.07 billion yuan, 3.75 billion yuan, and 4.52 billion yuan respectively, with corresponding EPS of 1.59, 1.94, and 2.35 yuan [10][12]

Investment Rating - The industry investment rating is "Positive (Maintained)" [6] Core Insights - The recent US-China Geneva trade talks have led to a significant reduction in tariffs on Chinese goods, with the effective tariff rate dropping from 125% to 34%, alleviating negative pressures on the supply chain [2] - Apple's price reduction on the iPhone 16 models aims to boost sales volume in the second quarter, which is typically a season for inventory clearance, thus positively impacting the supply chain [3] - The introduction of AI smartphones and foldable screens is expected to drive a new replacement cycle for iPhones, enhancing the average selling price (ASP) of core components in the supply chain [3] - The market sentiment around emerging terminal technologies, such as humanoid robots and AI glasses, has led to an increase in the price-to-earnings (PE) ratios of core suppliers, indicating potential for valuation recovery in the supply chain [4] - Recommended core supply chain stocks include Lens Technology, Linyang Technology, Xinwanda, and Pengding Holdings [5] Summary by Sections Section 1: Tariff Changes - The US has announced a temporary suspension of 24% tariffs on Chinese goods for 90 days, with only 10% remaining, effectively neutralizing the short-term impact of the tariff war on the supply chain [2] Section 2: iPhone Pricing Strategy - Apple's recent price cuts on the iPhone 16 Pro Max and Pro models, with reductions of $160 and $176 respectively, are aimed at increasing sales volume and supporting supply chain growth [1][3] Section 3: Future Innovations - The anticipated launch of AI smartphones and foldable devices is expected to create a new wave of demand, leading to a rise in ASP for core suppliers over the next two years [3] Section 4: Market Sentiment and Valuation - Despite the positive developments, the market has not fully recovered to pre-tariff levels, but the recent price cuts and tariff negotiations suggest a potential for valuation recovery in the supply chain [4]

证券研究报告 | 行业点评 | 消费电子 消费电子 报告日期：2025 年 05 月 13 日 对等关税暂缓消弭短期冲击，iPhone 16 降价夯实果链成长弹性 投资要点 ❑ 事件 1、中美日内瓦经贸会谈联合声明，美国将（一）修改 2025 年 4 月 2 日第 14257 号行政令中规定的对中国商品（包括香港特别行政区和澳门特别行政区商品）加 征的从价关税，其中，24%的关税在初始的 90 天内暂停实施，同时保留按该行 政令的规定对这些商品加征剩余 10%的关税；（二）取消根据 2025 年 4 月 8 日第 14259 号行政令和 2025 年 4 月 9 日第 14266 号行政令对这些商品的加征关税。 2、5 月 10 日，苹果向渠道商下发调价通知，iPhone 16 Pro Max 所有容量版本降 价 160 美元；iPhone 16 Pro 的 128GB 版本降价 176 美元，其他版本同样降价 160 美元。 ❑ 对等关税暂缓果链负面压力消弭 归纳此次声明内容：美国对我国商品加征的从价关税从 125%调降至 34%，其中 24%在初始的 90 天内暂停实施，这意味着之前关税战对果链的利空基本 ...